Tenderwize
Back to tender search

Open House Originale rebate agreements for Dapagliflozin

Techniker Krankenkasse·Hamburg, Germany·Deadline Aug 29, 2026 · 10 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-07 - Dapagliflozin

56/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

56 / 100

Complexity

48 / 100

Risk factors

Contracts cannot be submitted through the portal; they must be sent by email with qualified electronic signature or by...

Only pharmaceutical entrepreneurs meeting the AMG and authorisation conditions may participate.

Submission deadline in 10 days

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Aug 2026
  • Conclusion of rebate agreements for the medicinal product Dapagliflozin under Section 130c SGB V.
  • Uniform Open House terms apply; no individual negotiation of contract content.
Show full summary

Open House supply arrangement for Dapagliflozin pharmaceutical products in Germany, led by Techniker Krankenkasse with participating sickness funds. It is not a classic public procurement award procedure; contracts are concluded on uniform terms with all eligible pharmaceutical companies that meet the stated conditions. No contract value is stated. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and documents are only provided electronically to eligible companies.

Risks

Contracts cannot be submitted through the portal; they must be sent by email with qualified electronic signature or by...

Only pharmaceutical entrepreneurs meeting the AMG and authorisation conditions may participate.

Submission deadline in 10 days

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical entrepreneur within the meaning of Section 4(18) AMG for the relevant medicinal product.
  • Applicant must have its seat in the scope of the AMG, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal product or otherwise be entitled to place it on the market in its own name.

Award Criteria

Lot 1

Other criterion: participation and suitability requirements

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Originale rebate agreements for Dapagliflozin

Open House contract for rebate agreements under Section 130c SGB V for the active substance Dapagliflozin. Scope is nationwide in Germany. The lot information comes from structured data and the notice text. No lot value is stated. The procedure is open to eligible pharmaceutical companies during the contract period.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Aug 2024 - Aug 2026

Category

Pharmaceutical products

Award Criteria

Other criterion: participation and suitability requirements

Deadline

Deadline Aug 29, 2026

Procurement Details

Publication date
19 Jul 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
434034-2024

Documents (1)

Similar tenders